Cervical cancer mortality statistics

Deaths

Deaths from cervical cancer, 2016-2018, UK.

Percentage of all deaths

Percentage cervical cancer contributes to total cancer deaths, 2016-2018, UK

 

Age

Peak mortality rate for cervical cancer, 2016-2018, UK

Trend over time

Change in cervical cancer mortality rates since the early 1970s, Females, UK

Cervical cancer is the 19th most common cause of cancer death in females in the UK, accounting for 1% of all cancer deaths in females (2018).In females and males combined, cervical cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2018).[1-3]

Cervical cancer mortality rates (European age-standardised Open a glossary item (AS) rates Open a glossary item) for females are similar to the UK average in all the UK constituent countries.

For cervical cancer mortality rates do not vary between UK constituent nations however incidence rates do vary between the UK constituent nations.

Cervical Cancer (C53), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK, 2018

  England Scotland Wales Northern Ireland UK
Female Deaths 701 80 59 17 857
Crude Rate 2.5 2.9 3.7 1.8 2.5
AS Rate 2.5 2.8 3.6 1.9 2.6
AS Rate - 95% LCL 2.3 2.2 2.7 1.0 2.4
AS Rate - 95% UCL 2.7 3.4 4.6 2.9 2.7
Persons Deaths 701 80 59 17 857
Crude Rate 1.3 1.5 1.9 0.9 1.3
AS Rate 1.3 1.5 1.9 1.0 1.4
AS Rate - 95% LCL 1.2 1.2 1.4 0.5 1.3
AS Rate - 95% UCL 1.4 1.8 2.4 1.5 1.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rates Open a glossary item

See also

Cervical cancer incidence statistics by UK region

Cerival cancer survival statistics

Cancer mortality statistics for common cancers in the UK

References

  1. Data were provided by the Office for National Statistics on request, November 2019. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, June 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2018, C53.

Last reviewed:

Cervical cancer mortality is related to age, with the highest mortality rates being in older women. In the UK in 2016-2018, on average each year more than a quarter of deaths (29%) were in females aged 75 and over.[1-3] This is a lower proportion of deaths in older age groups compared with most cancers.

Age-specific mortality rates rise steadily from around age 20-24 and more steeply from around age 65-69. The highest rates are in the 90+ age group 

Cervical Cancer (C53), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Female Population, UK, 2016-2018

See also

Cervical cancer incidence statistics by age

Cervical cancer survival statistics by age

Cancer mortality statistics by age for all cancers

References

  1. Data were provided by the Office for National Statistics on request, November 2019. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, June 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016-2018, ICD-10 C53.

Last reviewed:

Cervical cancer European age-standardised Open a glossary item (AS) mortality rates for females decreased by 75% in the UK between 1971-1973 and 2016-2018.[1-3]

Over the last decade in the UK (between 2006-2008 and 2016-2018), cervical cancer AS mortality rates for females decreased by 18%.

Cervical Cancer (C53), European Age-Standardised Mortality Rates per 100,000 Population, Females, UK, 1971-2018

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Cervical cancer mortality rates have decreased overall in some broad adult age groups in females in the UK since the early 1970s, but have remained stable in others.[1-3] Rates in 20-24s have remained stable, in 25-34s have remained stable, in 35-49s have decreased by 66%, in 50-64s have decreased by 82%, in 65-79s have decreased by 77% and in 80+s have decreased by 67%.

Cervical Cancer (C53), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Females, UK, 1971-2018

See also

Cervical cancer incidence trends over time

Cervical cancer survival trends over time

Cervical cancer risk factors

Cervical cancer screening trends over time

References

  1. Data were provided by the Office for National Statistics on request, November 2019. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, June 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2018, C53

Last reviewed:

Projections which reflect past trends in cancer mortality suggest that cervical cancer mortality will fall slightly in future decades.[1] These projections do not model the possible impact of HPV vaccination on cervical cancer incidence rates, and the subsequent impact on mortality rates. If cervical cancer incidence rates fall markedly in future decades as projected,[2] cervical cancer mortality rates may also fall more markedly than projections based on past trends would suggest.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.
  2. Castanon A, Landy R, Pesola F, Windridge P, Sasieni P. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study. Lancet Public Health 2018;3(1):e34-e43.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C53

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for a strong association between cervical cancer mortality and deprivation in England.[1] European age-standardised Open a glossary item  mortality rates are 148% higher for females living in the most deprived areas in England compared with the least deprived, as shown for cervical cancer deaths during 2007-2011.[1]

Cervical Cancer (C53), European Age-Standardised Mortality Rates by Deprivation Quintile, Females, England, 2007-2011

The estimated deprivation gradient in cervical cancer mortality between females living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It is estimated that there would have been around 250 fewer cervical cancer deaths each year in England during 2007-2011 if all females experienced the same mortality rates as the least deprived.[1]

See also

Cancer mortality by socio-economic group

Deprivation gradient for cancer mortality

Deprivation gradient in cervical cancer incidence

Socio-economic variation in cancer mortality for Scotland

Socio-economic variation in cancer mortality for Wales

Socio-economic variation in cancer mortality for Northern Ireland

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C53

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.